peptide · regulated markets
How Peptide Influencer Marketing Works for Brands in 2026
A founder messaged me last Thursday wanting to book More Plates More Dates for her new BPC-157 brand. BPC-157 is a short-chain peptide some athletes use for soft-tissue recovery. The channel, run by Derek, has 2.05M subscribers and 169 sponsored videos across 14 brands since July 2024 in our log. The answer was no.
The brand stack tells you why. MPMD runs Gorilla Mind (Derek's own supplement brand, 49 deals) and a longevity brand called Intelligent (53 deals). Marek Health, a US testosterone and peptide telehealth clinic, has only one MPMD deal. The channel is locked into a non-Marek stack.
Across all peptide and GLP-1 posts we tagged, Marek Health alone accounts for 210 deals across 33 creators. Every new peptide brand has to plan around it before booking a first creator.
The deal log says concentration is the work
The bottleneck for a new peptide brand is not creator discovery. It is brand-conflict avoidance.
Our log shows 295 paid deals across 38 brands and 53 creators in the peptide and GLP-1 space. Marek Health holds 71 percent of those deals. Mochi Health (GLP-1 telehealth) holds another 43 deals across 9 creators. Orderlymeds (also GLP-1) holds 23, with 22 on Lorraine Kamesha at 59K subs. Simple Peptides has 18 deals, 17 of them with Dave the Lawyer.
A roster of 30 high-fit peptide creators already has Marek, Orderlymeds, Simple Peptides, or Mochi on a no-rival window. The brand entering has to pay one to defect or find long-tail creators those four have not booked yet. Here is the brand-stack read we run for every peptide brief.
Four kinds of creators that pass peptide brand review
The first is the high-volume retainer creator. MPMD at 2.05M subs with 169 sponsored videos is the top of the band. Flat rate high. Per-signup cost over six months the lowest in our database. Disclosure baked into the host's read.
The second is the patient-advocate creator. Mark Bell's Power Project at 384K subs with 20 Marek Health deals from December 2025 to April 2026 fits. The audience already uses TRT (testosterone replacement therapy) and peptides. After the first deal, the incumbent renews first every time.
The third is the named-category specialist. Lorraine Kamesha at 59K subs running 22 Orderlymeds deals as the GLP-1 voice is the model. Smaller audience. Far more signups per view.
The fourth is the podcast-host model. Chris Duffin reads for Enhanced Executive Peptides inside long episodes, building 30 to 60 seconds of context each time. That is the cadence a peptide brand needs to drive a $300-plus signup.
The Federal Trade Commission enforces influencer disclosure rules under 16 CFR Part 255. All four archetypes clear that bar. A wellness-aesthetic creator running her first peptide deal often does not.
The past-deal check before the first email
Ask one question before any candidate outreach. Did this creator run Marek Health, Orderlymeds, Simple Peptides, Mochi Health, or any GLP-1 brand inside the last 90 days? If yes, the no-rival window is active and the deal is dead before the first email.
Here is what a high-signal past-deal post looks like. TRT and Hormone Optimization closes its paid posts with hashtags #peptides #cjc1295 #tesamorelin #ipamorelin. CJC-1295 and tesamorelin are named research peptides. That hashtag block tells you the channel runs deep on peptide briefs and which brands have locked the slot.
Read the last 60 paid posts on every candidate by hand. The peptide-conflict filter alone cuts three of twelve names before hello. Disclosure-rate cuts two more. Rate-band cuts one more.
- Outreach lists scraped on a peptide hashtag with no brand-conflict check
- $5K stickers that land at $30K all-in once legal review and retakes hit
- Booking a creator already locked in a Marek-style no-rival window
Across 210 Marek Health deals and 33 creators in our sponsor log, six or more deals with one brand inside 12 months is the retainer signature. A competing brand approaching that creator for a one-off hits the conflict rejection every time.— Internal sponsor-deal log, Jul 2024 to Apr 2026Send me the 12-to-5 cut, free →
GLP-1 vs research peptides need different playbooks
GLP-1 telehealth in 2026 looks like the early-2010s telemedicine wave. The brand can run on YouTube and podcasts with standard disclosure. The FDA has warned 30 telehealth companies over illegal marketing of compounded GLP-1s. Brands that read those letters and stay inside the lane can still book creators safely.
Research-peptide marketing is harder. Most platforms refuse the brand outright. The read has to live inside a credentialed-host endorsement to survive. The Department of Defense flags BPC-157 as a prohibited peptide and an unapproved drug, which is the bar a research-peptide brief sits under.
The two playbooks share the past-deal check and the four archetypes. The brief, script review, and platform mix diverge.
Worried about the GLP-1 vs research-peptide split? Our deal log tags every creator by which side of the line their past briefs sit on, so the brief picks the right names before the lawyer ever reads a script. We share the read free for any peptide brief with a $25K-plus pilot budget.
Send us a peptide brief and we'll run the read →A GLP-1 brand can sit on a wellness lifestyle creator with a Mochi or Orderlymeds-style read. A research-peptide brand cannot. The only creators who clear platform review are the fitness-science and bodybuilding-podcast archetypes. Here is the archetype map we use to sort peptide rosters.
Twelve to five is the band a pilot should land in
The downside of a five-creator peptide pilot is bounded. One quarter of spend on creators that did not move the needle. The upside is a 12-month always-on roster, the same shape Marek Health built across 33 creators since July 2024.
Here is how a 12-creator shortlist shrinks to a signed roster. Start with 12. Lose 3 to active Marek, Orderlymeds, Simple Peptides, or Mochi rivals. Lose 2 to out-of-range rates. Lose 1 to a brand-safety review on research-peptide language. Lose 1 to a contracting ghost. That leaves 5 signed.
A pilot under three creators reads as noise. A pilot over eight overwhelms the legal review pipeline. Every script needs FDA-language review before publish. Five is the band that gives a clean 90-day read on archetype-by-archetype signup cost.
VigorousClips (27 Marek deals), Mark Bell's Power Project (20 deals, 384K subs), and SAMSON DAUDA (17 deals) show what always-on looks like once signed. Here is the deal-cadence read we send peptide brands before contracting.
Where We Come In
The downside of a sloppy peptide roster is a $60,000 quarter that lands on a creator with an active Marek Health deal or a missing FTC disclosure. The upside of a vetted five-creator pilot is the same always-on cadence Marek Health rode to 210 deals across 33 creators.
We read the past-deal history for every candidate, sort by archetype, run the discovery call, and bring you the five names that survived for a one-meeting sign-off. The brand-conflict map and per-post price for every name worth looking at already lives in our database. Speak with us when you want the roster built before outreach.
Frequently Asked Questions
Which peptide brand is most-sponsored in your database?
Marek Health leads with 210 deals across 33 creators. Mochi Health follows with 43 deals across 9 creators. Orderlymeds has 23 deals (22 on Lorraine Kamesha). Simple Peptides has 18 deals across 2 creators.
Can I run a peptide brand on TikTok or Meta in 2026?
Yes for GLP-1 telehealth brands with the right disclaimers. Mostly no for direct research-peptide promotion. The bulk of our 295 tracked deals lives on YouTube long-form, where the brief and disclosure flow can be vetted before publish.
What does a peptide-creator pilot cost over 90 days?
A 5-creator pilot in the mid-tier band runs around $25,000 to $40,000 a month. Podcast-host integrations cost more than mid-tail clip reads. Marek Health's cadence across 33 creators is the benchmark for what always-on looks like once a brand commits.
Reading loop
The 6 spoke posts that go deeper on a single peptide question:
Peptide creator vetting playbook. The 12-to-5 cut as a 30-minute SOP.
Platform rules for peptide on TikTok and Meta. What clears review.
Research-chemical loophole language to avoid. Script lines that trigger FDA or FTC scrutiny.
Medical claims vs research claims. The line that decides whether a script ships.
Peptide creator disclosure checklist. The clear-and-conspicuous bar for every paid read.
Peptide FTC warning letters analysis. What the latest enforcement sweep means.
Related: BPC-157 creator rate card, peptide retainer vs one-off cadence
Compliance: Peptide FTC warning letters analysis
Frequently asked
Which peptide brand is most-sponsored in your database?
Marek Health leads with 210 tracked sponsor deals across 33 creators in our log. Mochi Health, a GLP-1 weight-loss telehealth brand, follows with 43 deals across 9 creators. Orderlymeds, also GLP-1, has 23 deals (22 of them with one creator, Lorraine Kamesha). Simple Peptides has 18 deals across 2 creators.
Can I run a peptide brand on TikTok or Meta in 2026?
Yes for GLP-1 telehealth brands with the right disclaimers. Mostly no for direct research-peptide promotion. The bulk of our 295 peptide and GLP-1 paid posts lives on YouTube long-form. That is where the brief and disclosure flow can be vetted before publish.
What does a peptide-creator pilot cost over 90 days?
A 5-creator pilot in the mid-tier band runs around $25,000 to $40,000 a month. Podcast-host integrations cost more than mid-tail clip-channel reads. Marek Health's cadence across 33 creators is the benchmark for what always-on looks like once a brand commits.